Publications by authors named "M N Medina-Rosales"

Article Synopsis
  • The study investigates whether adding metastasis-directed therapy (MDT) to standard-of-care (SOC) systemic therapy improves progression-free survival (PFS) in patients with oligometastatic breast cancer.
  • A phase II randomized trial, EXTEND, included patients with up to five metastases and compared MDT plus SOC to SOC alone, measuring outcomes such as PFS and overall survival (OS).
  • Results from 43 patients showed no significant improvement in PFS or other secondary endpoints with MDT, suggesting it may not provide additional benefit for this patient group, albeit with limitations in study size and sample diversity.
View Article and Find Full Text PDF

Purpose: The EXTEND trial tested the hypothesis that adding comprehensive metastasis-directed therapy (MDT) to chemotherapy would improve progression-free survival (PFS) over chemotherapy alone among patients with oligometastatic pancreatic ductal adenocarcinoma (PDAC).

Methods: EXTEND (ClinicalTrials.gov identifier: NCT03599765) is a multicenter, phase II basket trial randomly assigning patients with ≤five metastases 1:1 to MDT plus systemic therapy versus systemic therapy.

View Article and Find Full Text PDF

Sodium selenite modulates the activity of lymphocytes. It negatively regulates the suppressive activity of cells and increases the immune response. In this study, we evaluated whether the regulatory T cell differentiation was modulated by sodium selenite.

View Article and Find Full Text PDF

Doxazosin and carvedilol have been evaluated as an alternative treatment against chronic liver lesions and for their possible role during the regeneration of damage caused by liver fibrosis in a hamster model. However, these drugs have been reported to induce morphological changes in hepatocytes, affecting the recovery of liver parenchyma. The effects of these /𝛽 adrenoblockers on the viability of hepatocytes are unknown.

View Article and Find Full Text PDF

is an intestinal parasite that causes dysentery and amebic liver abscess. has the capability to invade host tissue by union of virulence factor Gal/GalNAc lectin; this molecule induces an adherence-inhibitory antibody response as well as to protect against amebic liver abscess (ALA). The present work showed the effect of the immunization with PEIII-LC3-KDEL3 recombinant protein.

View Article and Find Full Text PDF